Whether you are searching for novel targets in a disease area, selecting patients for a therapeutic program, or prioritizing candidates from your existing platform — Impact Proteomics brings the antigen resolution capability to move your program forward. We start by understanding your biological question, then co-design the study, execute the platform workflows, and work with you to interpret what the immune system reveals. The relationship is iterative — we refine the approach as the data builds, and we are structured to grow with your program through co-discovery agreements and milestone-based collaborations.